Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts

Inclusion Criteria: * Patients with multiple plantar warts (≥ 3) will be included. Exclusion Criteria: * Patients under 18 years old or patients over 65 years old. * Pregnancy or breast feeding. * Patients received vaccination or any other treatment of warts during the last month. * Patients with a known sensitivity to any of the investigational product ingredients. * Patients with history of asthma, allergic skin disorders or convulsions. * Patients with signs of any systemic or local inflammation or infection. * Patients with any evidence of immunosuppression including HIV. * History of cardiac diseases, relevant abnormal K level or ECG abnormalities for patients who will receive the combined digoxin and furosemide.